Insulin degludec (Tresiba): new ultra long-acting basal insulin

Chaplin, Steve BPharm, MSc
Joseph, Frank MD, FRCP

Steve Chaplin is a pharmacist who specialises in writing on therapeutics

Declaration of interests None to declare.

Prescriber 24(17):p 17, September 5, 2013.

Insulin degludec is a new long-acting insulin for use in type 1 and 2 diabetes. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events, and Dr Frank Joseph discusses its place in diabetes treatment compared with other longacting insulins.